Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
HEMANGEOL is now available exclusively through Anovo Specialty Pharmacy to streamline access and therapy initiationEton has integrated full Eton Cares patient support, including $0 co-pay for eligible...
-
Washington, DC, April 30, 2026 (GLOBE NEWSWIRE) -- Howard University today announced the 158th Commencement Convocation will take place on Saturday, May 9, 2026, at 9:45 a.m., on the campus of the...
-
Arlington, VA, April 30, 2026 (GLOBE NEWSWIRE) -- ARLINGTON, VA — The National Automatic Merchandising Association welcomed more than 5,000 operators, suppliers, and industry professionals to The...
-
-- Total revenue of $177 million, reflecting increase of 5 percent over first quarter 2025 driven by growth across commercial portfolio, including EXPAREL volume growth of 7 percent -- -- Completed...
-
Detroit, MI, April 30, 2026 (GLOBE NEWSWIRE) -- The College for Creative Studies (CCS) has named Allison J. Puff as Provost and Vice President for Academic Affairs, the institution’s chief academic...
-
Highlights Aligned with the FDA in two Positive Type C meetings supporting key elements of the planned Phase 3 program for ATH434 in MSAAdvancing ATH434 toward pivotal Phase 3 program; on track for...
-
KT-621 (STAT6) parallel Phase 2b trials, BROADEN2 in atopic dermatitis and BREADTH in asthma, ongoing with data expected by mid-2027 and late 2027, respectively FDA granted Fast Track designation to...
-
Roche to present extensive data showcasing its industry-leading ophthalmology portfolio at ARVO 2026
New real-world data confirm Vabysmo’s potent retinal drying in nAMD and DMEKey data for Susvimo demonstrate its potential to provide lasting disease control through continuous delivery, while reducing...
-
NEW YORK, April 28, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that its pivotal...
-
WASHINGTON, April 28, 2026 (GLOBE NEWSWIRE) -- Compass Lexecon, a subsidiary of FTI Consulting, Inc. (NYSE: FCN), today announced that Dr. Ori Heffetz, a Professor of Economics at the S.C....